Salix Pharma CEO Carolyn Logan To Retire

(RTTNews) - Salix Pharmaceuticals, Ltd. (SLXP) said Monday that Carolyn Logan has informed the Board of her decision to retire as President and Chief Executive Officer, and as a director, of the company, effective January 30.

Ms. Logan will remain a consultant to the company.

Effective January 30, Tom D'Alonzo, Chairman of Salix's Board of Directors, will be appointed Acting Chief Executive Officer, and William Bertrand, Jr., the company's Senior Vice President and General Counsel, will be appointed Acting Chief Operating Officer, pending the company's hiring of a permanent Chief Executive Officer.

Salix said it plans to hire a nationally recognized executive search firm to assist the company in identifying a highly qualified, experienced pharmaceutical executive to lead the company on a going-forward basis.